Revance Therapeutics | RVNC - Kas Dan Setara



Kas Dan Setara Perubahan Tanggal
AbbVie USD 5.23B 400M 2025-12
ALKERMES USD 388.57M 227.88M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Cara Therapeutics USD 21.42M 770K 2025-09
Coherus Biosciences USD 88.88M 14.47M 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
J&J USD 19.71B 1.48B 2025-12
Merck USD 18.17B 10.16B 2025-09
Neurocrine Biosciences USD 713M 372.8M 2025-12
P&G USD 10.82B 346M 2025-12
Pacira USD 158.54M 10.96M 2025-12
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09